StockData
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$7.15−0.07 (-0.97%)

Close on Nov 17, 2026Market cap $741.49MP/E –Yield –

Aura Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Aura Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$103.01M. For fiscal 2025 it was -$84.74M. The highest annual figure on record is -$24.32M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$84.74M–
FY2024Dec 31, 2024-$79.81M–
FY2023Dec 31, 2023-$63.85M–
FY2022Dec 31, 2022-$54.60M–
FY2021Dec 31, 2021-$32.41M–
FY2020Dec 31, 2020-$24.32M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$32.50M–
Q1 FY2026Mar 31, 2026-$29.89M–
Q4 FY2025Dec 31, 2025-$20.47M–
Q3 FY2025Sep 30, 2025-$20.14M–
Q2 FY2025Jun 30, 2025-$20.77M–
Q1 FY2025Mar 31, 2025-$23.36M–
Q4 FY2024Dec 31, 2024-$23.95M–
Q3 FY2024Sep 30, 2024-$15.27M–
Q2 FY2024Jun 30, 2024-$16.13M–
Q1 FY2024Mar 31, 2024-$24.45M–
Q4 FY2023Dec 31, 2023-$17.39M–
Q3 FY2023Sep 30, 2023-$15.40M–
Q2 FY2023Jun 30, 2023-$14.65M–
Q1 FY2023Mar 31, 2023-$16.41M–
Q4 FY2022Dec 31, 2022-$18.01M–
Q3 FY2022Sep 30, 2022-$10.76M–
Q2 FY2022Jun 30, 2022-$10.63M–
Q1 FY2022Mar 31, 2022-$15.20M–
Q4 FY2021Dec 31, 2021-$12.09M–
Q3 FY2021Sep 30, 2021-$8.69M–
Q2 FY2021Jun 30, 2021-$6.50M–
Q1 FY2021Mar 31, 2021-$5.14M–
Q4 FY2020Dec 31, 2020-$3.76M–

More Aura Biosciences figures

See a number that looks wrong?